文献速递复苏、休克与脓毒症心脑血管急症

TAK242阻断Toll样受体4通路对脓毒症心肌损伤及心功能障碍的保护作用

[Protective effect of TAK242 blocking Toll-like receptor 4 pathway on septic myocardial injury and cardiac dysfunction].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论大鼠实验显示,TAK242预处理可阻断TLR4/NF-κB通路,减轻LPS诱导的脓毒症心肌损伤与心功能障碍。

研究将18只雄性SD大鼠随机分为对照组、脂多糖(LPS)组和TAK242预处理组(TAK242+LPS组),每组6只。LPS组腹腔注射LPS 15 mg/kg诱导脓毒症心功能障碍,TAK242+LPS组在LPS刺激前3小时腹腔注射TAK242 3 mg/kg。结果显示,TAK242+LPS组左心室舒张末容积和收缩末容积显著低于LPS组,左心室射血分数和缩短分数显著高于LPS组,血清肌钙蛋白显著降低,心肌IL-6、TNF-α mRNA、TLR4蛋白及p-NF-κB p65/NF-κB p65比值均显著降低。作者认为TAK242通过阻断TLR4介导的炎症反应保护LPS诱导的心功能障碍和心肌损伤。

要点

  • 大鼠脓毒症心功能障碍模型:LPS组LVEDV 118.01±11.89 μL、LVESV 32.70±9.22 μL显著高于对照组,LVEF 0.722±0.095、LVFS(42.37±8.71)%显著低于对照组。
  • TAK242+LPS组LVEDV 71.25±21.16 μL、LVESV 9.57±5.75 μL显著低于LPS组(均P<0.01),LVEF 0.868±0.075、LVFS(59.88±8.46)%显著高于LPS组(均P<0.05)。
  • TAK242+LPS组血清cTn 107.85±21.38 μg/L显著低于LPS组152.25±27.46 μg/L(P<0.05),心肌组织损伤明显减轻。
  • TAK242+LPS组心肌IL-6 mRNA 10.44±3.30、TNF-α mRNA 2.38±0.68、TLR4蛋白0.39±0.01、p-NF-κB p65/NF-κB p65比值1.21±0.11均显著低于LPS组(均P<0.05)。
  • LPS组心肌IL-6、TNF-α mRNA、TLR4蛋白及p-NF-κB p65/NF-κB p65比值均显著高于对照组,提示LPS诱导脓毒症激活心脏TLR4/NF-κB通路介导的炎症反应。

适用人群与场景

  • 雄性Sprague-Dawley(SD)大鼠,共18只,随机分为对照组、LPS组和TAK242+LPS组,每组6只。

处置流程与药物剂量

  • 脓毒症心功能障碍模型:腹腔注射LPS 15 mg/kg诱导,对照组给予等量生理盐水。
  • TAK242+LPS组在LPS刺激前3小时腹腔注射TAK242,剂量3 mg/kg,按0.2 g/L浓度溶于10%二甲基亚砜(DMSO)和90%玉米油;对照组和LPS组给予等量10% DMSO和90%玉米油。
  • 注射LPS后14小时行多普勒超声心动图检查心功能,取腹主动脉血用酶联免疫吸附试验(ELISA)测血清肌钙蛋白(cTn),取心肌组织行HE染色、qPCR检测IL-6和TNF-α mRNA、免疫组化观察TLR4蛋白、Western blotting检测TLR4、NF-κB p65及p-NF-κB p65水平。

研究设计与关键结果

  • 研究类型:动物实验;样本量:18只雄性SD大鼠,每组6只。
  • 心功能与心肌损伤:LPS组LVEDV和LVESV显著高于对照组,LVEF和LVFS显著低于对照组,光镜下见心肌细胞变性、坏死和炎性细胞浸润,血清cTn显著高于对照组,提示LPS诱导的脓毒症可导致心功能障碍和心肌损伤。
  • TAK242+LPS组LVEDV 71.25±21.16 μL vs LPS组118.01±11.89 μL,LVESV 9.57±5.75 μL vs 32.70±9.22 μL,均P<0.01;LVEF 0.868±0.075 vs 0.722±0.095,LVFS(59.88±8.46)% vs(42.37±8.71)%,均P<0.05;心肌组织损伤明显减轻,血清cTn 107.85±21.38 μg/L vs 152.25±27.46 μg/L,P<0.05。
  • 炎症指标:LPS组心肌IL-6和TNF-α mRNA表达、TLR4蛋白表达及p-NF-κB p65/NF-κB p65比值均显著高于对照组。
  • TAK242+LPS组IL-6 mRNA(2-ΔΔCT)10.44±3.30 vs LPS组107.50±29.48,TNF-α mRNA(2-ΔΔCT)2.38±0.68 vs 3.77±0.56,TLR4蛋白(TLR4/GAPDH)0.39±0.01 vs 0.58±0.04,p-NF-κB p65/NF-κB p65比值1.21±0.11 vs 2.10±0.18,均P<0.05。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠在体实验)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,TAK242可通过阻断TLR4介导的炎症反应,保护LPS诱导的心功能障碍和心肌损伤。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the role of Toll-like receptor 4 (TLR4) pathway on myocardial injury and cardiac dysfunction in septic rats.

METHODS: According to the random number table, 18 male Sprague-Dawley (SD) rats were divided into control group, lipopolysaccharide (LPS) group and TLR4 specific inhibitor TAK242 pretreatment group (TAK242+LPS group) with 6 rats in each group. The rat model of septic cardiac dysfunction was induced by intraperitoneal injection of LPS 15 mg/kg, and the control group was given the same amount of normal saline. The TAK242+LPS group was intraperitoneally given injection of TAK242 [it was injected intraperitoneally at a dose of 3 mg/kg and dissolved in 10% dimethyl sulfoxide (DMSO) and 90% corn oil according to the concentration of 0.2 g/L] 3 hours before LPS stimulation. The control group and LPS group were given the same amount of 10% DMSO and 90% corn oil. The cardiac function of rats in each group was examined by Doppler echocardiography 14 hours after injection of LPS. The blood of abdominal aorta was taken and the level of serum troponin (cTn) was measured by enzyme linked immunosorbent assay (ELISA). Myocardial tissue was harvested for hematoxylin-eosin (HE) staining, and the morphological changes of myocardial tissue were observed under light microscope. The mRNA expressions of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in myocardial tissue were detected by real-time fluorescence quantitative polymerase chain reaction (qPCR). The protein expression of TLR4 in myocardial tissue was observed by immunohistochemical method. Western blotting was used to detect the levels of TLR4, nuclear factor-κB p65 (NF-κB p65) and its phosphorylation (p-NF-κB p65) in myocardial tissue.

RESULTS: (1) The cardiac function and myocardial injury: Doppler echocardiography showed that the levels of left ventricular end-diastolic volume (LVEDV) and left ventricular end-systolic volume (LVESV) in the LPS group were significantly higher than those in the control group, while left ventricular ejection fraction (LVEF) and left ventricular shortened fraction (LVFS) were significantly lower than those in the control group. The degeneration, necrosis and inflammatory cell infiltration of cardiomyocytes were found with light microscope in the LPS group, and the levels of serum cTn were significantly higher than those in the control group, indicating that LPS-induced sepsis could cause cardiac dysfunction and myocardial injury. TAK242 blocking TLR4 pathway had a protective effect on cardiac function and myocardium during sepsis. LVEDV and LVESV in the TAK242+LPS group were significantly lower than those in the LPS group [LVEDV (μL): 71.25±21.16 vs. 118.01±11.89, LVESV (μL): 9.57±5.75 vs. 32.70±9.22, both P < 0.01]. LVEF and LVFS were significantly higher than those in the LPS group [LVEF: 0.868±0.075 vs. 0.722±0.095, LVFS: (59.88±8.46)% vs. (42.37±8.71)%, both P < 0.05]. Myocardial tissue injury was significantly reduced, and the serum cTn level was significantly lower than that in the LPS group (μg/L: 107.85±21.38 vs. 152.25±27.46, P < 0.05). (2) Inflammatory parameters: the results of qPCR, Western blotting and immunohistochemistry showed that the mRNA expressions of IL-6 and TNF-α, the expression of TLR4 protein and the p-NF-κB p65/NF-κB p65 ratio in the LPS group were significantly higher than those in the control group, indicating that LPS-induced sepsis could activate the inflammatory response mediated by TLR4/NF-κB pathway in the heart. However, blocking the TLR4 pathway by TAK242 could inhibit the TLR4/NF-κB pathway and reduce the myocardial inflammation in septic rats. The mRNA expressions of IL-6 and TNF-α, the expression of TLR4 protein and the p-NF-κB p65/NF-κB p65 ratio in the TAK242+LPS group were significantly lower than those in the LPS group [IL-6 mRNA (2-ΔΔCT): 10.44±3.30 vs. 107.50±29.48, TNF-α mRNA (2-ΔΔCT): 2.38±0.68 vs. 3.77±0.56, TLR4 protein (TLR4/GAPDH): 0.39±0.01 vs. 0.58±0.04, p-NF-κB p65/NF-κB p65 ratio: 1.21±0.11 vs. 2.10±0.18, all P < 0.05].

CONCLUSIONS: TAK242 can protect LPS-induced cardiac dysfunction and myocardial injury by blocking the TLR4 mediated inflammatory response.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Liu Z, Yang K, Deng T, et al. [Protective effect of TAK242 blocking Toll-like receptor 4 pathway on septic myocardial injury and cardiac dysfunction]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34955133. doi:10.3760/cma.j.cn121430-20210620-00915

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。